Healthcare -
Biotechnology - NASDAQ - US
$ 3.65
-12.7 %
$ 126 M
Market Cap
-3.88
P/E
GNLX - TOTAL EQUITY
Total Equity GNLX - Genelux Corporation
19.5 M
LAST VALUE
60.88%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR